| Species |
hsa |
hsa |
mmu |
rno |
gga |
dre |
dre |
cfa |
spo |
fca |
| Symbol |
CST3 |
CST1 |
Cst3 |
Cst3 |
CST3 |
cst3 |
zgc:163030 |
LOC607874 |
SPCC1450.07c |
CST3 |
| Function* |
cystatin C |
cystatin SN |
cystatin C |
cystatin C |
cystatin C |
cystatin C (amyloid angiopathy and cerebral hemorrhage) |
zgc:163030 |
cystatin-C-like |
putative D-amino acid oxidase |
cystatin C |
| Expression |
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
| Umap |
|
|
|
|
|
|
|
|
|
|
| Coexpression |
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| hsa04142 |
Lysosome |
5 |
 |
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| hsa04080 |
Neuroactive ligand-receptor interaction |
4 |
|
| hsa04972 |
Pancreatic secretion |
3 |
 |
| hsa04974 |
Protein digestion and absorption |
3 |
 |
| hsa05164 |
Influenza A |
3 |
 |
| hsa04970 |
Salivary secretion |
2 |
 |
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mmu04142 |
Lysosome |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| rno04142 |
Lysosome |
7 |
|
| rno03050 |
Proteasome |
3 |
|
| rno04612 |
Antigen processing and presentation |
2 |
|
| rno05163 |
Human cytomegalovirus infection |
2 |
|
| rno05168 |
Herpes simplex virus 1 infection |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| gga04142 |
Lysosome |
6 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| dre04142 |
Lysosome |
3 |
|
| dre00220 |
Arginine biosynthesis |
2 |
|
| dre00250 |
Alanine, aspartate and glutamate metabolism |
2 |
|
| dre00910 |
Nitrogen metabolism |
2 |
|
| dre04217 |
Necroptosis |
2 |
|
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| cfa04142 |
Lysosome |
8 |
|
| cfa05152 |
Tuberculosis |
4 |
|
| cfa04140 |
Autophagy - animal |
4 |
|
| cfa04145 |
Phagosome |
3 |
|
| cfa04210 |
Apoptosis |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| spo00230 |
Purine metabolism |
3 |
|
| spo00330 |
Arginine and proline metabolism |
3 |
|
| spo01240 |
Biosynthesis of cofactors |
2 |
|
| spo00260 |
Glycine, serine and threonine metabolism |
2 |
|
| spo00470 |
D-Amino acid metabolism |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| fca04142 |
Lysosome |
6 |
|
| fca00511 |
Other glycan degradation |
2 |
|
| fca00531 |
Glycosaminoglycan degradation |
2 |
|
| fca00600 |
Sphingolipid metabolism |
2 |
|
|
| GO BP* |
|
GO:0010711 [L] [N] negative regulation of collagen catabolic process
|
(1 genes)
|
|
GO:0060311 [L] [N] negative regulation of elastin catabolic process
|
(1 genes)
|
|
GO:0060313 [L] [N] negative regulation of blood vessel remodeling
|
(1 genes)
|
|
GO:0010716 [L] [N] negative regulation of extracellular matrix disassembly
|
(5 genes)
|
|
GO:0034103 [L] [N] regulation of tissue remodeling
|
(6 genes)
|
|
GO:0010466 [L] [N] negative regulation of peptidase activity
|
(13 genes)
|
|
GO:0097435 [L] [N] supramolecular fiber organization
|
(13 genes)
|
|
GO:0045861 [L] [N] negative regulation of proteolysis
|
(24 genes)
|
|
GO:0006952 [L] [N] defense response
|
(72 genes)
|
|
GO:1990000 [L] [N] amyloid fibril formation
|
(89 genes)
|
|
GO:0010951 [L] [N] negative regulation of endopeptidase activity
|
(149 genes)
|
|
GO:0044267 [L] [N] cellular protein metabolic process
|
(150 genes)
|
|
GO:0043687 [L] [N] post-translational protein modification
|
(344 genes)
|
|
GO:0043312 [L] [N] neutrophil degranulation
|
(484 genes)
|
|
|
GO:0001580 [L] [N] detection of chemical stimulus involved in sensory perception of bitter taste
|
(41 genes)
|
|
GO:0010951 [L] [N] negative regulation of endopeptidase activity
|
(149 genes)
|
|
|
GO:0043067 [L] [N] regulation of programmed cell death
|
(7 genes)
|
|
GO:0045740 [L] [N] positive regulation of DNA replication
|
(35 genes)
|
|
GO:0060548 [L] [N] negative regulation of cell death
|
(103 genes)
|
|
GO:0006979 [L] [N] response to oxidative stress
|
(124 genes)
|
|
GO:0010466 [L] [N] negative regulation of peptidase activity
|
(126 genes)
|
|
GO:0008284 [L] [N] positive regulation of cell population proliferation
|
(548 genes)
|
|
|
GO:0010711 [L] [N] negative regulation of collagen catabolic process
|
(1 genes)
|
|
GO:0060311 [L] [N] negative regulation of elastin catabolic process
|
(1 genes)
|
|
GO:0010716 [L] [N] negative regulation of extracellular matrix disassembly
|
(3 genes)
|
|
GO:0060313 [L] [N] negative regulation of blood vessel remodeling
|
(3 genes)
|
|
GO:0007431 [L] [N] salivary gland development
|
(5 genes)
|
|
GO:0042747 [L] [N] circadian sleep/wake cycle, REM sleep
|
(5 genes)
|
|
GO:0034103 [L] [N] regulation of tissue remodeling
|
(6 genes)
|
|
GO:0043067 [L] [N] regulation of programmed cell death
|
(7 genes)
|
|
GO:0097435 [L] [N] supramolecular fiber organization
|
(11 genes)
|
|
GO:0001775 [L] [N] cell activation
|
(13 genes)
|
|
GO:0010466 [L] [N] negative regulation of peptidase activity
|
(17 genes)
|
|
GO:0060009 [L] [N] Sertoli cell development
|
(19 genes)
|
|
GO:0009743 [L] [N] response to carbohydrate
|
(22 genes)
|
|
GO:0045861 [L] [N] negative regulation of proteolysis
|
(28 genes)
|
|
GO:0010035 [L] [N] response to inorganic substance
|
(34 genes)
|
|
GO:0045740 [L] [N] positive regulation of DNA replication
|
(38 genes)
|
|
GO:0006952 [L] [N] defense response
|
(45 genes)
|
|
GO:0001654 [L] [N] eye development
|
(46 genes)
|
|
GO:0048678 [L] [N] response to axon injury
|
(57 genes)
|
|
GO:0007566 [L] [N] embryo implantation
|
(65 genes)
|
|
GO:0034599 [L] [N] cellular response to oxidative stress
|
(94 genes)
|
|
GO:0070301 [L] [N] cellular response to hydrogen peroxide
|
(98 genes)
|
|
GO:0060548 [L] [N] negative regulation of cell death
|
(103 genes)
|
|
GO:0009636 [L] [N] response to toxic substance
|
(122 genes)
|
|
GO:0006979 [L] [N] response to oxidative stress
|
(148 genes)
|
|
GO:0008584 [L] [N] male gonad development
|
(158 genes)
|
|
GO:0010951 [L] [N] negative regulation of endopeptidase activity
|
(168 genes)
|
|
GO:0031667 [L] [N] response to nutrient levels
|
(172 genes)
|
|
GO:0032355 [L] [N] response to estradiol
|
(213 genes)
|
|
GO:0001666 [L] [N] response to hypoxia
|
(285 genes)
|
|
GO:0014070 [L] [N] response to organic cyclic compound
|
(285 genes)
|
|
GO:0007420 [L] [N] brain development
|
(361 genes)
|
|
GO:0006915 [L] [N] apoptotic process
|
(370 genes)
|
|
GO:0042493 [L] [N] response to drug
|
(519 genes)
|
|
GO:0008284 [L] [N] positive regulation of cell population proliferation
|
(578 genes)
|
|
|
GO:0010951 [L] [N] negative regulation of endopeptidase activity
|
(20 genes)
|
|
|
|
|
|
GO:0019478 [L] [N] D-amino acid catabolic process
|
(1 genes)
|
|
GO:0046416 [L] [N] D-amino acid metabolic process
|
(1 genes)
|
|
GO:0046436 [L] [N] D-alanine metabolic process
|
(1 genes)
|
|
GO:1902114 [L] [N] D-valine metabolic process
|
(1 genes)
|
|
|
| GO CC* |
|
GO:1904724 [L] [N] tertiary granule lumen
|
(55 genes)
|
|
GO:1904813 [L] [N] ficolin-1-rich granule lumen
|
(124 genes)
|
|
GO:0005788 [L] [N] endoplasmic reticulum lumen
|
(306 genes)
|
|
GO:0005794 [L] [N] Golgi apparatus
|
(992 genes)
|
|
GO:0005783 [L] [N] endoplasmic reticulum
|
(1041 genes)
|
|
GO:0005615 [L] [N] extracellular space
|
(1824 genes)
|
|
GO:0005576 [L] [N] extracellular region
|
(1946 genes)
|
|
GO:0070062 [L] [N] extracellular exosome
|
(2212 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4709 genes)
|
|
|
GO:0005615 [L] [N] extracellular space
|
(1824 genes)
|
|
|
GO:0043292 [L] [N] contractile fiber
|
(19 genes)
|
|
GO:0005771 [L] [N] multivesicular body
|
(56 genes)
|
|
GO:0005604 [L] [N] basement membrane
|
(115 genes)
|
|
GO:0031982 [L] [N] vesicle
|
(163 genes)
|
|
GO:0031965 [L] [N] nuclear membrane
|
(195 genes)
|
|
GO:0062023 [L] [N] collagen-containing extracellular matrix
|
(319 genes)
|
|
GO:0005764 [L] [N] lysosome
|
(427 genes)
|
|
GO:0030424 [L] [N] axon
|
(441 genes)
|
|
GO:0043025 [L] [N] neuronal cell body
|
(613 genes)
|
|
GO:0048471 [L] [N] perinuclear region of cytoplasm
|
(668 genes)
|
|
GO:0042995 [L] [N] cell projection
|
(1117 genes)
|
|
GO:0005794 [L] [N] Golgi apparatus
|
(1367 genes)
|
|
GO:0005783 [L] [N] endoplasmic reticulum
|
(1582 genes)
|
|
GO:0005576 [L] [N] extracellular region
|
(1738 genes)
|
|
GO:0005615 [L] [N] extracellular space
|
(1801 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4367 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(6992 genes)
|
|
|
GO:0043292 [L] [N] contractile fiber
|
(18 genes)
|
|
GO:0005771 [L] [N] multivesicular body
|
(44 genes)
|
|
GO:0005604 [L] [N] basement membrane
|
(110 genes)
|
|
GO:0042995 [L] [N] cell projection
|
(147 genes)
|
|
GO:0031982 [L] [N] vesicle
|
(158 genes)
|
|
GO:0031965 [L] [N] nuclear membrane
|
(219 genes)
|
|
GO:0005764 [L] [N] lysosome
|
(304 genes)
|
|
GO:0030424 [L] [N] axon
|
(469 genes)
|
|
GO:0043025 [L] [N] neuronal cell body
|
(622 genes)
|
|
GO:0048471 [L] [N] perinuclear region of cytoplasm
|
(738 genes)
|
|
GO:0005576 [L] [N] extracellular region
|
(781 genes)
|
|
GO:0005794 [L] [N] Golgi apparatus
|
(1022 genes)
|
|
GO:0005783 [L] [N] endoplasmic reticulum
|
(1042 genes)
|
|
GO:0005615 [L] [N] extracellular space
|
(1412 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4480 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(5068 genes)
|
|
|
GO:0005615 [L] [N] extracellular space
|
(218 genes)
|
|
|
GO:0005615 [L] [N] extracellular space
|
(875 genes)
|
|
|
GO:0005615 [L] [N] extracellular space
|
(875 genes)
|
|
|
|
GO:0005737 [L] [N] cytoplasm
|
(1314 genes)
|
|
|
| GO MF* |
|
GO:0030414 [L] [N] peptidase inhibitor activity
|
(14 genes)
|
|
GO:0004869 [L] [N] cysteine-type endopeptidase inhibitor activity
|
(34 genes)
|
|
GO:0004866 [L] [N] endopeptidase inhibitor activity
|
(40 genes)
|
|
GO:0001540 [L] [N] amyloid-beta binding
|
(88 genes)
|
|
GO:0002020 [L] [N] protease binding
|
(102 genes)
|
|
GO:0042802 [L] [N] identical protein binding
|
(1498 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(12443 genes)
|
|
|
GO:0004869 [L] [N] cysteine-type endopeptidase inhibitor activity
|
(34 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(12443 genes)
|
|
|
GO:0004866 [L] [N] endopeptidase inhibitor activity
|
(33 genes)
|
|
GO:0004869 [L] [N] cysteine-type endopeptidase inhibitor activity
|
(46 genes)
|
|
GO:0001540 [L] [N] amyloid-beta binding
|
(67 genes)
|
|
GO:0030414 [L] [N] peptidase inhibitor activity
|
(125 genes)
|
|
GO:0002020 [L] [N] protease binding
|
(156 genes)
|
|
GO:0042802 [L] [N] identical protein binding
|
(1906 genes)
|
|
|
GO:0030414 [L] [N] peptidase inhibitor activity
|
(16 genes)
|
|
GO:0004866 [L] [N] endopeptidase inhibitor activity
|
(26 genes)
|
|
GO:0004869 [L] [N] cysteine-type endopeptidase inhibitor activity
|
(41 genes)
|
|
GO:0001540 [L] [N] amyloid-beta binding
|
(68 genes)
|
|
GO:0002020 [L] [N] protease binding
|
(123 genes)
|
|
GO:0042802 [L] [N] identical protein binding
|
(1829 genes)
|
|
|
GO:0004869 [L] [N] cysteine-type endopeptidase inhibitor activity
|
(1 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(122 genes)
|
|
|
GO:0004869 [L] [N] cysteine-type endopeptidase inhibitor activity
|
(17 genes)
|
|
|
GO:0004869 [L] [N] cysteine-type endopeptidase inhibitor activity
|
(17 genes)
|
|
|
|
GO:0003884 [L] [N] D-amino-acid oxidase activity
|
(1 genes)
|
|
GO:0071949 [L] [N] FAD binding
|
(10 genes)
|
|
|
| KEGG* |
| 04970 |
Salivary secretion |
 |
|
| 04970 |
Salivary secretion |
|
|
| 04970 |
Salivary secretion |
|
|
| 04970 |
Salivary secretion |
|
|
|
|
|
| 04970 |
Salivary secretion |
|
|
| 00260 |
Glycine, serine and threonine metabolism |
|
| 00330 |
Arginine and proline metabolism |
|
| 00470 |
D-Amino acid metabolism |
|
| 04146 |
Peroxisome |
|
|
| 04970 |
Salivary secretion |
|
|
| Entrez Gene ID* |
1471 |
1469 |
13010 |
25307 |
396497 |
791878 |
566959 |
607874 |
2539033 |
100462660 |
